Canon (7751) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Jul, 2025Executive summary
Markets remained stable, but performance was significantly impacted by yen appreciation compared to the same period last year.
New products drove growth in camera sales; network camera sales grew nearly 20%, and medical posted strong sales growth.
Second quarter net sales decreased by 2.4% year-over-year to ¥1,140.2B, while first-half net sales rose 2% to ¥2,198.6B, the highest since 2007.
Profits increased by 8% in 1H and 20% in local currency, reflecting improved profitability.
Basic EPS for Q2 was ¥92.05; first-half EPS was ¥169.16, both up year-over-year.
Financial highlights
2Q 2025 net sales ¥1,140.2B, down 2.4% year-over-year; up 2% in local currency.
2Q operating profit ¥117.8B, down 0.5% year-over-year; up 17.6% excluding FX impact.
2Q net income ¥83.7B, down 6.9% year-over-year; 1H net income ¥155.9B, up 4.1% year-over-year.
Gross margin for 2Q at 46.9%, slightly lower than 47.2% last year; operating expense to sales ratio improved to 36.6%.
1H 2025 net sales ¥2,198.6B, up 2% year-over-year; operating profit ¥214.3B, up 8%.
Outlook and guidance
Full-year 2025 net sales projected at ¥4,600B (+2% year-over-year), operating profit ¥460B (+3.4%), net income ¥330B (+1.5%).
Guidance revised downward due to U.S. tariffs, global economic uncertainty, and postponed investments.
Dividend per share forecast for 2025 is ¥160, targeting a 50% payout ratio.
Aiming for operating profit ratio of 10% and raising dividend by ¥5 to ¥160 for the year.
Assumes U.S. tariffs remain at 10% through year-end.
Latest events from Canon
- Record sales and profit growth in 2025, with further gains and higher margins projected for 2026.7751
Q4 202529 Jan 2026 - Record Q2 sales and profit growth, with raised full-year outlook and strong segment results.7751
Q2 202426 Jan 2026 - Record sales and profit growth in Q3 2024, led by Printing and Imaging, with a strong full-year outlook.7751
Q3 202426 Jan 2026 - Record sales in 2024, Medical goodwill hit, but 2025 profit rebound expected.7751
Q4 202426 Jan 2026 - Record sales offset by profit pressure from tariffs; guidance lowered, dividend raised.7751
Q3 202527 Oct 2025 - Record Q1 sales and profit growth, led by strong imaging and printing momentum.7751
Q1 20256 Jun 2025